Ingredient record · Anti-infective for gut, dental and other infections
Metronidazole: bans, restrictions and failed batches in India
Last checked 3 November 2026. Sources: CDSCO banned-drugs notifications and monthly NSQ alerts, Jan 2019 to Sep 2026
14 entries containing Metronidazole are on India's banned-drugs list, and 7 are banned today. 50 batches of medicines containing Metronidazole failed a government lab test between March 2019 and September 2026, from 43 manufacturers. A failed batch concerns that batch only, not the medicine or every brand.
7
Banned combinations in force
7
Other listed orders (stayed, restricted, quashed)
50
Batches failed a lab test
Sep 2026
Latest lab alert
Is it banned? Our answer pages
Not banned · three combinations prohibited (2024)
On the banned-drugs list
Metronidazole on its own is not on CDSCO's banned list. The entries below are specific combinations that contain it. Status follows CDSCO's own notes on each entry.
| Drug / combination | Action | Notification | Date | Order | Status note |
|---|---|---|---|---|---|
| Rifaximin 200mg + Metronidazole 400mg TabletsFixed-dose combination · antibiotics | Halted | CDSCO F.No. 4-01/2023-DC (Misc. 3) dated 11.04.2025, Annexure Sr. 24 | 11 April 2025 | 35 FDCs · Apr 2025 | CDSCO direction to state licensing authorities, 11 Apr 2025, not a Section 26A gazette ban |
| Norfloxacin 125mg + Metronidazole 120mg + Simethicone 10mg SuspensionFixed-dose combination · antibiotics | Halted | CDSCO F.No. 4-01/2023-DC (Misc. 3) dated 11.04.2025, Annexure Sr. 26 | 11 April 2025 | 35 FDCs · Apr 2025 | CDSCO direction to state licensing authorities, 11 Apr 2025, not a Section 26A gazette ban |
| Povidone Iodine + Metronidazole + AloeFixed-dose combination · skin | Banned | S.O. 3308(E) | 2 August 2024 | 156 FDCs · Aug 2024 | Prohibited under s.26A; notifications dated 02.08.2024, gazetted 21-22 Aug 2024. |
| Ofloxacin + Metronidazole + Zinc AcetateFixed-dose combination · antibiotics | Banned | S.O. 4436(E) | 7 September 2018 | 328 FDCs · Sep 2018 | In force per CDSCO list as on 22.11.2021 |
| Metronidazole + NorfloxacinFixed-dose combination · antibiotics | Banned | S.O. 4445(E) | 7 September 2018 | 328 FDCs · Sep 2018 | In force per CDSCO list as on 22.11.2021 |
| Metronidazole + TetracyclineFixed-dose combination · antibiotics | Banned | S.O. 4447(E) | 7 September 2018 | 328 FDCs · Sep 2018 | In force per CDSCO list as on 22.11.2021 |
| Furazolidone + Metronidazole + LoperamideFixed-dose combination · antibiotics | Banned | S.O. 4507(E) | 7 September 2018 | 328 FDCs · Sep 2018 | In force per CDSCO list as on 22.11.2021 |
| Norfloxacin + Metronidazole + Zinc AcetateFixed-dose combination · antibiotics | Banned | S.O. 4510(E) | 7 September 2018 | 328 FDCs · Sep 2018 | In force per CDSCO list as on 22.11.2021 |
| Ofloxacin + Metronidazole + Zinc AcetateFixed-dose combination · antibiotics | Quashed | S.O. 767(E) | 10 March 2016 | 344 FDCs · Mar 2016 | Quashed by Delhi HC 1 Dec 2016; see 2018 re-ban |
| Metronidazole + NorfloxacinFixed-dose combination · antibiotics | Quashed | S.O. 776(E) | 10 March 2016 | 344 FDCs · Mar 2016 | Quashed by Delhi HC 1 Dec 2016; see 2018 re-ban |
| Metronidazole + TetracyclineFixed-dose combination · antibiotics | Quashed | S.O. 779(E) | 10 March 2016 | 344 FDCs · Mar 2016 | Quashed by Delhi HC 1 Dec 2016; see 2018 re-ban |
| Furazolidone + Metronidazole + LoperamideFixed-dose combination · antibiotics | Quashed | S.O. 844(E) | 10 March 2016 | 344 FDCs · Mar 2016 | Quashed by Delhi HC 1 Dec 2016; see 2018 re-ban |
| Norfloxacin + Metronidazole + Zinc AcetateFixed-dose combination · antibiotics | Quashed | S.O. 847(E) | 10 March 2016 | 344 FDCs · Mar 2016 | Quashed by Delhi HC 1 Dec 2016; see 2018 re-ban |
| Nalidixic Acid with any Anti-Amoebic Including MetronidazoleFixed-dose combination · antibiotics | Banned | GSR 170(E) | 12 March 2001 | Classic bans | In force per CDSCO consumer list (1983-2017) |
Products that failed lab tests
Product names as printed by the testing labs, grouped. Open a product to see every batch number.
| Product | Batches | Makers | Latest |
|---|---|---|---|
| Metronidazole | 34 | 27 | Aug 2026 |
| Povidone Iodine Metronidazole | 4 | 4 | Jul 2026 |
| Ofloxacin Metronidazole | 3 | 3 | May 2026 |
| Ofloxacin Metronidazole Simethicone | 2 | 2 | Jul 2026 |
| Metronidazole Furazolidone Loperamide Hcl Bolus | 1 | 1 | Sep 2026 |
| Metronidazole W/v | 1 | 1 | Jul 2026 |
| Elcares Metronidazole | 1 | 1 | Jun 2025 |
| Metronidazole Furazolidone | 1 | 1 | Dec 2023 |
| Ofloxacin Metronidazole Benzoate | 1 | 1 | Aug 2023 |
| Dixogyl | 1 | 1 | Nov 2021 |
| Metronidazole Benzoate | 1 | 1 | Jun 2019 |
Most recent failed batches
| Product | Batch | Manufacturer | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|---|
| Metronidazole, Furazolidone & Loperamide HCL Bolus (Vet) | Batch WT-002Mfg Mar 2025 · Exp Feb 2027 | Therawin FormulationsHaryana | Test for Disintegration onlyDisintegration | RDTL, Hubli, KarnatakaState lab | Sep 2026 |
| Metronidazole Tablets IP 400mg | Batch IT6050Mfg Feb 2026 · Exp Jan 2029 | Inducare Pharmaceutical and Research FoundatiionMaharashtra | 1.The Content of Metronidazole in the Sample is less (i.e. 32.44% of stated Amount) the I.P. Limits. (I.P. Limit: Not less than 90% and not more than 110% of stated Amount). 2. The Sample does not Comply with IP requirements for the Dissolution Test. The Sample is declared as Misbranded Vide Rule 96: Section 17(c) of the Drugs and Cosmetics Act 1940 and Rules 1945, as Manufacturer has stated, 1.Tablets are film Coated but, the Tablets are found uncoated. 2. Each Film Coated Tablet contains: Metronidazole Tablets IP 400 mg, Instead of Metronidazole IP400 mg.Dissolution | FDAL, MumbaiState lab | Aug 2026 |
| Metronidazole Tablets IP 200mg | Batch IT6151Mfg Feb 2026 · Exp Jan 2029 | Inducare Pharmaceutical and Research FoundatiionMaharashtra | 1. Content of Metronidazole in the Sample is less (i.e. 52.75% of stated Amount) than the I.P. Limits. (I.P. Limit: Not less than 90% and not more than 110% of stated Amount). 2.The Sample does not Comply with IP requirements for the Dissolution Test. The Sample is declared as Misbranded Vide Rule 96: Section 17(c) of the Drugs and Cosmetics Act 1940 and Rules 1945, as Manufacturer has stated, The Tablets are film Coated but, the Tablets are found uncoated.Dissolution | FDAL, MumbaiState lab | Aug 2026 |
| Ofloxacin Metronidazole and Simethicone Suspension | Batch OXG2501Mfg Sep 2025 · Exp Aug 2027 | Apple Formulations Pvt. LtdUttarakhand | Content of Metronidazole (45.68%)Other | Drugs Testing Laboratory, Madurai-19State lab | Jul 2026 |
| Metronidazole and Povidone Iodine Ointment | Batch XOJM25015Mfg Jul 2025 · Exp Jun 2027 | Helios Pharmaceuticals (Div. of P.K.T.P. Pvt LtdHimachal Pradesh | The sample does not conform to Label claim with respect to the content of Availabe Iodine in Povidone Iodine(79.59%)Labelling | Drugs Testing Laboratory, Madurai-19State lab | Jul 2026 |
| Metronidazole Tablets IP 400 mg | Batch T4500Mfg Nov 2024 · Exp Apr 2027 | Titanes Pharma | The sample does not conforms to the IP with respect to Dissolution.Dissolution | DTL JaipurState lab | Jul 2026 |
| Metronidazole Tablets IP 200 mg | Batch MZ241001Mfg Oct 2024 · Exp Sep 2026 | Cipco Pharmaceuticals 35-36/1Madhya Pradesh | The Dissolution test Does Not Complies as per IP Specification, hence it is of Not of Standard Quality.Dissolution | DCL, TelanganaState lab | Jul 2026 |
| Metronidazole Tablets IP 200 mg | Batch ME025002Mfg Dec 2025 · Exp Nov 2028 | Danish Healthcare (P) Ltd. 76/27-29 | Uniformity of WeightUniformity of weight/content | Lucknow LabState lab | Jul 2026 |
| Metronidazole Infusion B.P. 0.5% w/v | Batch L04A032607Mfg Mar 2026 · Exp Feb 2029 | Althea Pharma Pvt. LtdDaman & Diu | The sample does not comply as per B.P. 2025 with respect to the test for Sterility.Sterility | RDTL, GuwahatiCDSCO lab | Jul 2026 |
| Povidone-Iodine & Metronidazole Ointment | Batch 25343AMfg Aug 2025 · Exp Jul 2027 | Athens Life SciencesHimachal Pradesh | ContentOther | DTL, Madurai-19State lab | Jun 2026 |
| Ofloxacin & Metronidazole Suspension | Batch CF610Mfg Nov 2025 · Exp Oct 2027 | Biva HealthcareGujarat | The sample does not conform to claim with respect to the test of Identification and Assay of Metronidazole and OfloxacinAssay | CDL, KolkataCDSCO lab | May 2026 |
| Metronidazole Tablets IP 400 mg | Batch MET23027SLMfg May 2025 · Exp Apr 2027 | Shiva Biogenetic Laboratories Pvt. LtdHimachal Pradesh | DissolutionDissolution | SDT&RL, BhubaneswarState lab | Mar 2026 |
| Ofloxacin, Metronidazole & Simethicone Suspension | Batch ZRSL - 1533Mfg Jun 2025 · Exp May 2027 | ZRS Pharmaceuticals India Pvt. LtdHimachal Pradesh | The sample does not conform to claim as per Patent and Proprietary in respect to the Assay of Ofloxacin.Assay | RDTL, ChandigarhCDSCO lab | Jan 2026 |
| Metronidazole Tablets I.P. 400 mg. | Batch MT-24027Mfg May 2024 · Exp Apr 2026 | Medivs Biosciences Pvt. LtdUttar Pradesh | The sample does not comply as per I.P. 2022 with respect to the test for Dissolution of Metronidazole.Dissolution | RDTL,GuwahatiCDSCO lab | Jan 2026 |
| Povidone - Iodine & Metronidazole Ointment | Batch 5C10Mfg Mar 2025 · Exp Feb 2027 | Zenith Drugs Pvt. LtdMadhya Pradesh | ContentOther | Drugs Testing Laboratory, Chennai-06State lab | Nov 2025 |
Showing 15 of 50 records
Holding a strip or bottle? The batch number is printed after "B. No." Check it against every alert. If it matches, return it to the pharmacy. What the labels mean: status guide.